Skip to main content
MTEX
NASDAQ Life Sciences

Mannatech Appoints Yasir Haider as Permanent CFO Amidst Turnaround Efforts

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Positive
Importance info
7
Price
$5.63
Mkt Cap
$10.864M
52W Low
$3.8
52W High
$12.454
52W Position info
48% above low
Off High info
55% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

MTEX sits 48% above its 52-week low of $3.8.

Summary

Mannatech has appointed Yasir Haider as its permanent Chief Financial Officer, a move that provides leadership stability as the company navigates financial challenges and builds on its recent Q1 profit.


Key Events · Executive and Board Changes · MTEX

  • Permanent CFO Appointment

    Yasir Haider has been appointed Chief Financial Officer and principal financial officer, effective June 3, 2026.

  • Transition from Interim Role

    Mr. Haider previously served as Interim CFO since March 20, 2026, and as the Company's Controller since January 2025, indicating an internal promotion.

  • Leadership Stability

    This appointment provides crucial financial leadership stability for Mannatech, which recently reported a Q1 profit after facing significant financial challenges and a Nasdaq delisting notice.

  • CEO Endorsement

    President and CEO Landen Fredrick praised Mr. Haider for bringing discipline and focus to financial processes, expressing confidence in his leadership.


Analysis · MTEX · Life Sciences

This appointment formalizes Yasir Haider's role as Chief Financial Officer, transitioning him from an interim position. For a company that recently faced a "going concern" warning and Nasdaq delisting threats, securing a permanent CFO with experience in SEC reporting and financial operations is a crucial step towards stability and effective management of its financial turnaround, building on the positive Q1 results.

How filings like this one have moved

In the 30 days to Oct 3, 2026, 28.8% of the 1640 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.58%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MTEX was trading at $5.63 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.9M. The 52-week trading range was $3.80 to $12.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MTEX - Latest Insights

MTEX
Aug 12, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.07
Real-time Price: $6.64 info
Change: +$1.57 (+31%) info
Market Cap: $12.813M info
MTEX
Aug 12, 2026, 4:02 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.07
Real-time Price: $6.64 info
Change: +$1.57 (+31%) info
Market Cap: $12.813M info
MTEX
May 20, 2026, 2:37 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $3.98
Real-time Price: $6.64 info
Change: +$2.66 (+67%) info
Market Cap: $12.813M info
MTEX
May 14, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.62
Real-time Price: $6.64 info
Change: +$2.02 (+44%) info
Market Cap: $12.813M info
MTEX
May 14, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.62
Real-time Price: $6.64 info
Change: +$2.02 (+44%) info
Market Cap: $12.813M info